Ascendis Pharma A/S Increase Decrease Through Transactions With Owners
Ascendis Pharma A/S (ASND) reported Increase Decrease Through Transactions With Owners of EUR 87.08 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners · last filed 2026-02-11
- Ascendis Pharma A/S increase decrease through transactions with owners for the quarter ending 2025-12-31 was 15.35M EUR, a 406.30% increase year-over-year.
- Ascendis Pharma A/S increase decrease through transactions with owners for the quarter ending 2025-09-30 was 45.42M EUR, a 85.63% decline year-over-year.
- Ascendis Pharma A/S increase decrease through transactions with owners for the quarter ending 2025-06-30 was 12.47M EUR, a 3315.89% increase year-over-year.
- Ascendis Pharma A/S increase decrease through transactions with owners for the quarter ending 2025-03-31 was 13.83M EUR, a 34.77% decline year-over-year.
| Period end | Increase Decrease Through Transactions With Owners 3 month | Increase Decrease Through Transactions With Owners 6 month | Increase Decrease Through Transactions With Owners 9 month | Increase Decrease Through Transactions With Owners 12 month | Increase Decrease Through Transactions With Owners 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 15.35M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 60.78M EUR derived: sum of 2 quarters · filed 2026-02-11 | 73.24M EUR derived: sum of 3 quarters · filed 2026-02-11 | 87.08M EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 45.42M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 57.89M EUR derived: sum of 2 quarters · filed 2025-11-12 | 71.73M EUR 6-K · filed 2025-11-12 | 74.76M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-06-30 | 12.47M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 26.30M EUR 6-K · filed 2025-08-07 | 29.33M EUR derived: sum of 3 quarters · filed 2026-02-11 | 345.52M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2025-03-31 | 13.83M EUR 6-K · filed 2025-05-01 | 16.87M EUR derived: sum of 2 quarters · filed 2026-02-11 | 333.05M EUR derived: sum of 3 quarters · filed 2026-02-11 | 333.42M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-12-31 | 3.03M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 319.22M EUR derived: sum of 2 quarters · filed 2026-02-11 | 319.58M EUR derived: sum of 3 quarters · filed 2026-02-11 | 340.79M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 316.19M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 316.55M EUR derived: sum of 2 quarters · filed 2025-11-12 | 337.76M EUR 6-K · filed 2025-11-12 | 339.78M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-06-30 | 365.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 21.57M EUR 6-K · filed 2025-08-07 | 23.59M EUR derived: sum of 3 quarters · filed 2026-02-11 | 29.79M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2024-03-31 | 21.21M EUR 6-K · filed 2025-05-01 | 23.23M EUR derived: sum of 2 quarters · filed 2026-02-11 | 29.42M EUR derived: sum of 3 quarters · filed 2026-02-11 | 29.63M EUR derived: sum of 4 quarters · filed 2026-02-11 | |
| 2023-12-31 | 2.02M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 8.21M EUR derived: sum of 2 quarters · filed 2026-02-11 | 8.42M EUR derived: sum of 3 quarters · filed 2026-02-11 | 10.29M EUR 20-F · filed 2026-02-11 | |
| 2023-09-30 | 6.19M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 6.40M EUR derived: sum of 2 quarters · filed 2024-11-14 | 8.27M EUR 6-K · filed 2024-11-14 | 16.53M EUR derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | 208.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | 2.07M EUR 6-K · filed 2024-09-03 | 10.34M EUR derived: sum of 3 quarters · filed 2025-02-12 | 11.67M EUR derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | 1.87M EUR 6-K · filed 2024-05-02 | 10.13M EUR derived: sum of 2 quarters · filed 2025-02-12 | 11.46M EUR derived: sum of 3 quarters · filed 2025-02-12 | 11.77M EUR derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | 8.26M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 9.60M EUR derived: sum of 2 quarters · filed 2025-02-12 | 9.90M EUR derived: sum of 3 quarters · filed 2025-02-12 | 10.29M EUR 20-F · filed 2025-02-12 | 5.15M EUR 20-F · filed 2023-02-16 |
| 2022-09-30 | 1.34M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 1.64M EUR derived: sum of 2 quarters · filed 2023-11-07 | 2.02M EUR 6-K · filed 2023-11-07 | 4.35M EUR derived: sum of 4 quarters · filed 2024-02-07 | |
| 2022-06-30 | 301.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 686.00K EUR 6-K · filed 2023-09-05 | 3.01M EUR derived: sum of 3 quarters · filed 2024-02-07 | 395.30M EUR derived: sum of 4 quarters · filed 2024-02-07 | |
| 2022-03-31 | 385.00K EUR 6-K · filed 2023-04-27 | 2.71M EUR derived: sum of 2 quarters · filed 2024-02-07 | 395.00M EUR derived: sum of 3 quarters · filed 2024-02-07 | 397.80M EUR derived: sum of 4 quarters · filed 2024-02-07 | |
| 2021-12-31 | 2.33M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 394.61M EUR derived: sum of 2 quarters · filed 2024-02-07 | 397.41M EUR derived: sum of 3 quarters · filed 2024-02-07 | 399.39M EUR 20-F · filed 2024-02-07 | |
| 2021-09-30 | 392.29M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 395.09M EUR derived: sum of 2 quarters · filed 2022-11-02 | 397.07M EUR 6-K · filed 2022-11-02 | 408.68M EUR derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-06-30 | 2.80M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 4.78M EUR 6-K · filed 2022-08-10 | 16.39M EUR derived: sum of 3 quarters · filed 2023-02-16 | 633.60M EUR derived: sum of 4 quarters · filed 2023-02-16 | |
| 2021-03-31 | 1.98M EUR 6-K · filed 2022-05-11 | 13.59M EUR derived: sum of 2 quarters · filed 2023-02-16 | 630.80M EUR derived: sum of 3 quarters · filed 2023-02-16 | ||
| 2020-12-31 | 11.61M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 628.82M EUR derived: sum of 2 quarters · filed 2023-02-16 | 638.80M EUR 20-F · filed 2023-02-16 | ||
| 2020-09-30 | 617.21M EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | 627.19M EUR 6-K · filed 2021-11-10 | |||
| 2020-06-30 | 9.98M EUR 6-K · filed 2020-08-27 | ||||
| 2019-12-31 | 5.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 8.16M EUR derived: sum of 2 quarters · filed 2022-03-02 | 17.38M EUR derived: sum of 3 quarters · filed 2022-03-02 | 529.33M EUR 20-F · filed 2022-03-02 | |
| 2019-09-30 | 2.85M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | 12.07M EUR derived: sum of 2 quarters · filed 2020-11-12 | 524.02M EUR 6-K · filed 2020-11-12 | 524.95M EUR derived: sum of 4 quarters · filed 2021-03-10 | |
| 2019-06-30 | 9.22M EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | 521.17M EUR 6-K · filed 2020-08-27 | 522.10M EUR derived: sum of 3 quarters · filed 2021-03-10 | 524.17M EUR derived: sum of 4 quarters · filed 2021-03-10 | |
| 2019-03-31 | 511.95M EUR 6-K · filed 2020-05-19 | 512.88M EUR derived: sum of 2 quarters · filed 2021-03-10 | 514.95M EUR derived: sum of 3 quarters · filed 2021-03-10 | 518.32M EUR derived: sum of 4 quarters · filed 2021-03-10 | |
| 2018-12-31 | 925.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 3.00M EUR derived: sum of 2 quarters · filed 2021-03-10 | 6.36M EUR derived: sum of 3 quarters · filed 2021-03-10 | 216.38M EUR 20-F · filed 2021-03-10 | |
| 2018-09-30 | 2.07M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 5.43M EUR derived: sum of 2 quarters · filed 2019-11-18 | 215.46M EUR 6-K · filed 2019-11-18 | 233.06M EUR derived: sum of 4 quarters · filed 2020-04-03 | |
| 2018-06-30 | 3.37M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 213.39M EUR 6-K · filed 2019-08-28 | 230.99M EUR derived: sum of 3 quarters · filed 2020-04-03 | 345.86M EUR derived: sum of 4 quarters · filed 2020-04-03 | |
| 2018-03-31 | 210.03M EUR 6-K · filed 2019-05-30 | 227.63M EUR derived: sum of 2 quarters · filed 2020-04-03 | 342.49M EUR derived: sum of 3 quarters · filed 2020-04-03 | 342.49M EUR derived: sum of 4 quarters · filed 2020-04-03 | |
| 2017-12-31 | 17.60M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 132.47M EUR derived: sum of 2 quarters · filed 2020-04-03 | 132.47M EUR derived: sum of 3 quarters · filed 2020-04-03 | 133.11M EUR 20-F · filed 2020-04-03 | |
| 2017-09-30 | 114.86M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | 114.86M EUR derived: sum of 2 quarters · filed 2018-11-28 | 115.50M EUR 6-K · filed 2018-11-28 | ||
| 2017-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | 644.00K EUR 6-K · filed 2018-08-29 | |||
| 2017-03-31 | 644.00K EUR 6-K · filed 2018-05-30 | ||||
| 2016-12-31 | 125.97M EUR 20-F · filed 2019-04-03 | ||||
| 2015-12-31 | 114.14M EUR 20-F · filed 2018-03-28 |